Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.

Deck, D.H., Jordan, J.M., Holland, T.L. et al. (4 more authors) (2016) Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting. Infectious Diseases and Therapy. ISSN 2193-8229

Abstract

Metadata

Authors/Creators:
  • Deck, D.H.
  • Jordan, J.M.
  • Holland, T.L.
  • Fan, W.
  • Wikler, M.A.
  • Sulham, K.A.
  • Ralph Corey, G.
Copyright, Publisher and Additional Information: © The Author(s) 2016. Published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.
Keywords: Acute bacterial skin and skin structure infections (ABSSSI); Eron classification; Oritavancin; Outpatient
Dates:
  • Published: 1 July 2016
  • Published (online): 1 July 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 25 Aug 2016 08:27
Last Modified: 25 Aug 2016 08:27
Published Version: http://dx.doi.org/10.1007/s40121-016-0119-9
Status: Published
Publisher: Adis, Springer Healthcare
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40121-016-0119-9
Related URLs:

Download

Share / Export

Statistics